Can a genetic test tell me if tirzepatide will work for me?

No single test can determine whether a specific medication will work for you. PGx results provide additional genetic context for your prescriber to consider.

Do I need a prescription to get tested?

No. NextGen PGx testing does not require a prescription. Any medication decisions, including whether to start or continue tirzepatide, remain with your prescribing healthcare provider.

NextGen PGx

Tirzepatide Genetic Testing

Genetic Testing for Tirzepatide Response

Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for weight management and blood sugar control. NextGen PGx testing reports genetic variants studied for their possible relevance to medication-processing pathways relevant to this medication class.

What a tirzepatide-related PGx report can offer

Your NextGen PGx report reviews genetic variants associated with relevant metabolic pathways and presents them with clear evidence-level context — never as a guarantee of outcome.

Talking to your prescriber

Bring your NextGen PGx report to your next appointment. Your prescriber can weigh the genetic information alongside your health history, current medications, and treatment goals.

FAQ

Questions, answered

Ready to learn what your genetics can tell you?

Order your NextGen PGx PGx test today and get a unique patient ID in minutes.

Related Resources

GLP-1 Genetic Testing Semaglutide Genetic Testing Weight Loss Medication Genetic Test GLP-1 Medication Response Deep Dive

Tirzepatide is marketed under brand names including Mounjaro® and Zepbound®, registered trademarks of Eli Lilly and Company. NextGen PGx is not affiliated with, sponsored by, or endorsed by Eli Lilly and Company.